Cargando…
The safety and efficacy of high dose ferric carboxymaltose in patients with chronic kidney disease: A single center study
Ferric carboxymaltose (FCM) is a parenteral, dextran-free iron formulation designed to overcome the limitations of existing intravenous (IV) iron preparations. We investigated the safety and efficacy of high dose administration of FCM in our anemic chronic kidney disease (CKD) patients. It was a pro...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495475/ https://www.ncbi.nlm.nih.gov/pubmed/26199472 http://dx.doi.org/10.4103/0971-4065.144421 |